Categories

Category: THCB Spotlights

THCB Spotlights: Lightbeam Health Solutions

By ZOYA KHAN

Today, THCB is spotlighting Lightbeam Health Solutions. Lightbeam is an end-to-end population health management solution, which means they build everything from the ground up (i.e. no acquisitions or 3rd party interfaces are used). “Interface to innovation” as Jorge Miranda, CRO of Lightbeam, states, allows Lightbeam to build a health system’s value-based contracts relatively quickly. Their main focus is to generate data insights for ACOs and other provider systems, to engage care teams in the coordination of patient care. This is Lightbeam’s 6th year in the health care field, and with 100 customers and over 20 million patients in their enterprise data warehouse (EDW), they have no signs of slowing down.

Lightbeam has 4 main focuses: data ingestion, data insights, the engagement of the team with the data gathered, and the patient outcomes that result from that data. Lightbeam seeks to use their insights to empower care teams by giving the information back to the caregivers, physicians, and patients. According to them, this creates more transparency in the entire process as well as allows the patient and caregivers to play an active role in their health care process.

The ultimate value that clients (health systems or providers) receive from Lightbeam’s system is cutting costs and improving quality. Lightbeam does this by monitoring engagement numbers and patient outcomes based on the data and insights they gathered, ensuring costs savings for clients as well as an effective approach to cutting the high cost of care today. Lightbeam’s ultimate goal is to replace a manual process that is currently being done by multiple people and using multiple resources, to refocus the target on improving care for everyone involved in the health care system.

Zoya Khan is the Editor-in-Chief of THCB as well as an Associate at SMACK.health, a health-tech advisory service for early-stage startups.

THCB Spotlights: eyeforPharma

By ZOYA KHAN

Jessica DaMassa interviews Paul Simms, the Chairman of eyeforpharma. Eyeforpharma are the “media moguls” when it comes to the Pharma industry. In order to innovate the industry, they are holding two different conferences this year to bring pharma leaders and health technology startups together to foster relationships and strategic partnerships with one another. Their first conference will be held in Barcelona in March, and the second one will be in Philadelphia in April.

Paul speaks to Jess about how health tech startups are maturing in their ways and realizing that health care is an institutionalized game, causing them to pivot their companies’ directions to fit that model. He also comments on how the pharmaceutical industry is trying to build strong relationships with particular startups to innovate their business practices, whether it be in R&D, drug discovery, or clinical research. Paul argues that the future of Pharma is more akin to a platform model, where pharma companies are not just limited to their internal capacity but are much more reliant on a larger ecosystem of moving parts that will help develop and grow the space. He also mentions that Pharma companies could really benefit from taking a page out of Google’s or Facebook’s business model which allows people to innovate and create their own content on these platforms. He further states that large B2C companies, like Amazon, will change the entire game of how people receive and curate their health insurance plans. 

eyeforphrama’s conference theme is “medicine is just the beginning”. Paul and his team believe if they bring together specific groups of people, it will benefit the pharmaceutical industry in the short term as well as the long term. Paul believes that “Pharma companies need to have a wider portfolio of innovation that goes far beyond medicine, whether that is drug+plus a solution or without the pill at all.”  Currently, Paul states, that the merging of pharma companies with other pharma companies is like having “s*x with your cousins” and believes that Pharma companies need to bridge out of their own space to keep up with the times. If you are a startup in this space, be sure to check out eyeforpharma’s upcoming conferences.

Zoya Khan is the Editor-in-Chief of The Health Care Blog and an Associate at SMACK.health

THCB Spotlight: Jesse Ehrenfeld, AMA

By ZOYA KHAN

Today, we are featuring Dr. Jesse Ehrenfeld from the American Medical Association (AMA) on THCB Spotlight. Matthew Holt interviews Dr. Ehrenfeld, Chair-elect of the AMA Board of Trustees and an anesthesiologist with the Vanderbilt University School of Medicine. The AMA has recently released their Digital Health Implementation Playbook, which is a guide to adopting digital health solutions. They also launched a new online platform called the Physician Innovation Network to help connect physicians with entrepreneurs and developers. Watch the interview to find out more about how the AMA is supporting health innovation, as well as why the AMA thinks the CVS-Aetna merger is not a good idea and how the AMA views the role of AI in the future of health care.

Zoya Khan is the Editor-in-Chief of THCB as well as an Associate at SMACK.health, a health-tech advisory services for early-stage startups.

THCB Spotlights: Livio AI

By ZOYA KHAN

Today we are featuring another #TechCrunchDisrupt2018 THCB Spotlight. Matthew Holt interviews LivioAI, which is an AI hearing aid created by Starkey Technologies. Worldwide, there are 700 Million people with hearing loss but only 10% wear a device to help them. That number is appalling especially because there are a number of co-morbid illnesses linked with hearing loss, like cognitive and physical decline! That is where LivioAI comes in to play. LivioAI is completely controlled by your iPhone, tracks all types of movements (it is always counting your steps so the steps you miss when you put down are also accounted for), classifies acoustic environments to measure your social engagement (it can register the difference between a noisy restaurant and a library to figure out how much you are participating in a situation), and even translates foreign languages directly into your ear with its voice-activated platform. It is connected with Apple Health and Google Fit and can measure data to observe patterns of co-morbid illnesses. It is the new Fitbit, but for the ear! As LivioAI’s motto goes “Hear better, Live better.”

Zoya Khan is the Editor-in-Chief of THCB as well as an Associate at SMACK.health, a health-tech advisory services for early-stage startups.

THCB Spotlights: CY5

By ZOYA KHAN

I know we have been bombarding you all with a bunch of videos and announcements, but there are some really interesting pieces of health tech that are launching and events that are happening in the Fall. Today I wanted to spotlight another really cool startup that Matthew met with at #TechCrunchDisrupt18 called CY-5 (pronounced Sci-5, trust me Matthew & I kept calling it C-Y-5). Their company is developing biometric temporary tattoos to track your vitals. Right now their tattoos can measure your heart rate and your inter-cranial pressure. Also, strangely enough, their tattoos are designed and printed onto a special paper that conducts electricity- that means it requires no exterior electricity source to monitor your biometrics! It is all in the design of the product that powers the tattoo. Their focus right now is to test their product out in the elderly population. For all of you out there that can’t get real tattoos, this would look really cool plus it would track your vitals and keep you healthy- double win.

Zoya Khan is the Editor-in-Chief of THCB as well as an Associate at SMACK.health, a health-tech advisory services for early-stage startups.

THCB Spotlights: TestCard

By ZOYA KHAN

A few weeks back, Matthew met with TestCard (another Brit like him) at TechCrunch Disrupt 2018. Greg, from TestCard, spoke to Matthew about how their device can test multiple different illnesses using urine and a clinical grade camera, which then spits out results (almost) immediately on your smartphone. Currently, the device can be used for detecting pregnancy, glucose, STIs, UTIs, and many more diseases. Their focus is on preventative care for patients, so they are working with insurance companies to use their product as a kit to diagnose problems that are prevalent in UK’s population. Not to mention their slogan is “A bit like Theranos, but our flagship products work.”

Zoya Khan is the Editor-in-Chief of THCB as well as an Associate at SMACK.health, a health-tech advisory services for early-stage startups.

Registration

Forgotten Password?